Search Results - "Arrate, Maria P."
-
1
TLR3 agonism augments CD47 inhibition in acute myeloid leukemia
Published in Haematologica (Roma) (01-07-2024)“…CD47-SIRPa is a myeloid check point pathway that promotes phagocytosis of cells lacking markers for self-recognition. Tumor cells can overexpress CD47 and bind…”
Get full text
Journal Article -
2
Pevonedistat and azacitidine upregulate NOXA (PMAIP1) to increase sensitivity to venetoclax in preclinical models of acute myeloid leukemia
Published in Haematologica (Roma) (01-04-2022)“…Dysregulation of apoptotic machinery is one mechanism by which acute myeloid leukemia (AML) acquires a clonal survival advantage. B-cell lymphoma protein-2…”
Get full text
Journal Article -
3
BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid Leukemia
Published in Clinical cancer research (15-01-2021)“…The BCL2 inhibitor, venetoclax, has transformed clinical care in acute myeloid leukemia (AML). However, subsets of patients do not respond or eventually…”
Get full text
Journal Article -
4
Selective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromes
Published in Haematologica (Roma) (01-02-2023)“…Treatment for myelodysplastic syndromes (MDS) remains insufficient due to clonal heterogeneity and lack of effective clinical therapies. Dysregulation of…”
Get full text
Journal Article -
5
Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
Published in Cancer research (Chicago, Ill.) (01-04-2024)“…Impairing the BET family coactivator BRD4 with small-molecule inhibitors (BETi) showed encouraging preclinical activity in treating acute myeloid leukemia…”
Get full text
Journal Article -
6
Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignancies
Published in Blood advances (11-02-2020)“…The selective inhibitor of nuclear export (SINE) compounds selinexor (KPT-330) and eltanexor (KPT-8602) are from a novel class of small molecules that target…”
Get full text
Journal Article -
7
Electron Transport Chain Complex V Inhibition Enhances the Antileukemic Activity of Low-Dose Venetoclax in Acute Myeloid Leukemia
Published in Blood (15-11-2022)Get full text
Journal Article -
8
Lactate Utilization Provides a Metabolic Escape to Resist the Antileukemic Activity of BET Inhibition in Acute Myeloid Leukemia
Published in Blood (15-11-2022)Get full text
Journal Article -
9
Primary HSPC-Derived Monocytes with DNMT3A p.R882H Exhibit Activated Myeloid Cell Gene Signatures
Published in Blood (15-11-2022)Get full text
Journal Article -
10
DNMT3A R882H Exhibits Greater Inflammatory Potential Than R882C in Primary Hematopoietic Stem and Progenitor Cell Knock-in Model and Population Data
Published in Blood (02-11-2023)“…Clonal hematopoiesis (CH) is an age-associated phenomenon which is known to increase the risk for hematologic malignancy and cardiovascular disease. The most…”
Get full text
Journal Article -
11
Abstract LB-168: MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract Lung cancer is the leading cause of cancer deaths and yet the genes that drive this malignancy are not entirely known. MicroRNA (miRNA) are important…”
Get full text
Journal Article -
12
Abstract 1768: The oncogene Mdmx promotes genomic instability independent of p53
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Abstract Mdmx is upregulated in many human cancers. As a member of the Mdm2 protein family, Mdmx functions similar to Mdm2 as a negative regulator of the tumor…”
Get full text
Journal Article